Investors unfazed by drug-patent expiry
David Brindley(Orbus Therapeutics (United States)), Chris Mason(Oak Ridge National Laboratory), Brock Reeve(Harvard Stem Cell Institute)
Cited by 4
Related Papers
A Brief Definition of Regenerative Medicine
|Regenerative Medicine|2007|795
BTRFS
|ACM Transactions on Storage|2013|381
Lancet Commission: Stem cells and regenerative medicine
|The Lancet|2017|276
Cell Therapy Industry: Billion Dollar Global Business with Unlimited Potential
|Regenerative Medicine|2011|144
Peak Serum: Implications of Serum Supply for Cell Therapy Manufacturing
|Regenerative Medicine|2011|144